Get Startedvalethealth2024-03-23T23:01:05+00:00

Get Started with PearlPAK™

Begin your journey to better brain health today with our HIPAA-compliant questionnaire to see if PearlPAK™* is right for you.

Start Free Questionnaire Now!

Get Started with PearlPAK™

Begin your journey to better brain health today with our HIPAA-compliant HealthFit™ questionnaire to see if PearlPAK™ is right for you.

Start Free Brain Fog Quiz

Interested in more information?

Learn how it works

Download the complete process.

The PearlPAK™ Process

The CleopatraRX™ team is ready to facilitate your connection with a medical practitioner and pharmacy to prescribe a PearlPAK™ treatment plan tailored to fit your needs.

Begin your journey to better brain health today and prevent brain fog during menopause with PearlPAK™.

Step 1: Qualification

STEP 1: QUALIFICATION

Step 1: Qualification

Begin with the online HealthFit™ questionnaire to determine if PearlPAK™ is right for you.

After completing the survey, your responses are sent to a CleopatraRX medical practitioner.

Step 2: Appointment

STEP 2: APPOINTMENT

Step 2: Appointment

The medical practitioner will contact you via text or email to schedule a free telemedicine consultation.

During the call, the practitioner will ask additional questions to provide to one of our board-certified HIPPA-compliant consulting physicians. The physician will further review your health information and communicate if PearlPAK™ is a good fit for you. If approved and you choose to move forward, the physician will write a prescription.

Step 3: Prescription Delivered

STEP 3: PRESCRIPTION DELIVERED

Step 3: Prescription Delivered

The PearlPAK™ prescription is sent to our compounding pharmacy partner and delivered directly to your door.

Within 7 business days, a 3-month dose of PearlPAK™ arrives at your door with instructions to begin treatment.

Step 4: Follow Up

STEP 4: FOLLOW-UP

Step 4: Follow Up

The medical practitioner will contact you after 2-months to ask how you feel and to determine if the dosage amount should be adjusted or remain the same.

Untitled design – 2023-12-31T154106.841

STEP 5: REFILL PRESCRIPTION

Untitled design – 2023-12-31T154106.841

After the follow-up, the medical practitioner will send a refill prescription to the pharmacy for another 3-month dose.

© Copyright 2024 CleopatraRX™. All Rights Reserved. View our Privacy Policy.

*PearlPAK™️ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and is used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product for use as a drug/routine system and/or treatment.

The PearlPAK™️ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post-menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.

*PearlPAK™ dose system is not intended to treat neurological diseases including dementia and Alzheimer’s Disease. It is specifically designed to target cognitive difficulties in perimenopause and early menopausal women only. If you are concerned about neurological disease or have a family history of neurological disease, contact your physician.

CleopatraRX™ and PearlPAK™ are trademarks of CleopatraRX Development, LLC. CleopatraRX™ is a service mark and used throughout this website to represent the services offered by CleopatraRX Development, LLC. PearlPAK™ is a dosage product is for use as a drug/routine system and/or treatment.

The PearlPAK™ drug/routine system is protected by U.S. Patent No. 10,369,158 – PHARMACEUTICAL PACKAGING FOR ESTRIOL THERAPY – which relates to novel packaged pharmaceutical products for the treatment of neurodegenerative diseases, such as multiple sclerosis, and methods of using these products.

Estriol Therapy U.S. Patent No. 9,962,395 – COMPOSITIONS AND METHODS FOR MAINTAINING COGNITIVE FUNCTION – Provides methods for reducing the progression of cognitive decline in a post – menopausal woman using a continuous regimen of estrogen in combination with periodic administration of a progestogen.